Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1996-10-04
2000-07-04
Ketter, James
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C07K 500
Patent
active
060840684
ABSTRACT:
The functional domains of Elongin A having transcriptional activation activity and Elongin BC binding activity and the functional domains of Elongin C having Elongin A activation activity and Elongin A and/or Elongin C binding activity have now been identified and isolated.
REFERENCES:
patent: 5310667 (1994-05-01), Eichholtz et al.
patent: 5464756 (1995-11-01), Henner et al.
Database Swissprot; YRL4 CAEEL (AC 009413), Oct. 1, 1996, Swinburne J.: "Hypothetical 49.2 kd Protein R03D7.4 in Chromosome II,"XP002055270.
Tan, et al., "Dissection of transcription factor TFIIF functional domains required for initiation and elongation," Proc Natl Acad Sci USA 92:6042-6046 (Jun., 1995).
Aso, et al., "The RNA polymerase II elongation complex," FASEB J 9:1419-1428 (1995).
Aso, et al., "Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II," Science 269:1439-1443 (1995).
Bradsher, et al., "RNA polymerase II transcription factor SIII. I. Identification, purification and properties," J Biol Chem 268:25587-25593 (1993).
Bradsher, et al., "RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation," J Biol Chem 268:25594-25603 (1993).
Chen, et al., "Characterization of a HeLa cDNA clone encoding the human SII protein, an elongation factor for RNA polymerase II," Gene 116:253-258 (1992).
Chen, et al., "Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype," Human Mutation 5:66-75 (1995).
Cipres-Palacin, G. and Kane, C.M., "Cleavage of the nascent transcript induced by TFIIS in insufficient to promote read-through of intrinsic blocks to elongation by RNA polymerase II," Proc Natl Acad Sci USA 91:8087-8091 (1994).
Conaway, R.C. and Conaway, J.W., "General initiation factors for RNA polymerase II," Annu Rev Biochem 62:161-190 (1993).
Conaway, et al., "Mechanism of assembly of the RNA polymerase II preinitiation complex," J Biol Chem 267:10142-10148 (1992).
Conaway, et al., "Transcription initiated by RNA polymerase II and transcription factors from liver," J Biol Chem 266:7804-7811 (1991).
Conaway, J.W. and Conaway, R.C., "An RNA polymerase II transcription factor shares functional properties with Esherichia coli, " Science 248:1550-1553 (1990).
Conaway, R.C. and Conaway, J.W., "ATP activates transcription initiation from promoters by RNA polymerase II in a reversible step prior to RNA synthesis," J Biol Chem 263:2962-2968 (1988).
Duan, et al., "Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations," Proc Natl Acad Sci USA 92:6459-6463 (1995).
Duan, et al., "Inhibition of transcription elongation by the VHL tumor suppressor protein," Science 269:1402-1406 (1995).
Eng, et al., "Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I," J Biol Chem 264:13373-13376 (1989).
Foster, et al., "Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma," Human Molecular Genetics 3:2169-2173 (1994).
Garrett, et al., "Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog," Proc Natl Acad Sci USA 92:7172-7176 (1995).
Garrett, et al., "Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII," Proc Natl Acad Sci USA 91:5237-5241 (1994).
Gnarra, et al., "Mutations of the VHL tumour suppressor gene in renal carcinoma," Nat Genet 7:85-90 (1994).
Gorbalenya, et al., "Two related superfamilies of putative helicases involved in replication, recombination, repair, and expression of DNA and RNA genomes," Nucleic Acids Res 17:4713-4730 (1989).
Iliopoulos, et al., "Tumour suppression by the human von Hippel-Lindau gene product," Nature Medicine 1:822-826 (1995).
Ingraham, et al., "The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions," Cell 61:1021-1033 (1990).
Kadesch, T.R. and Chamberlin, M.J., "Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template," J Biol Chem 257:5286-5295 (1982).
Kane, C.M., "Transcript elongation and gene regulation in eukaryotes," Transcription: Mechanisms and Regulation, R.C. Conaway and J.W. Conaway, eds., Raven Press, New York, pp. 279-296 (1994).
Kanno, et al., "Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas," Cancer Research 54:4845-4847 (1994).
Kibel, et al., "Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C," Science 269:1444-1446 (1995).
Krumm, et al., "Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation," Genes Dev 9:559-572 (1995).
Latif, et al., "Identification of the von Hippel-Lindau disease tumor suppressor gene," Science 260:1317-1320 (1993).
Lynn, et al., "Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomease I," Proc Natl Acad Sci USA 86:3559-3563 (1989).
Marshall, N.F. and Price, D.H., "Purification of P-TEFb, a transcription factor required for the transition into productive elongation," J Biol Chem 270:12335-12338 (1995).
Marshall, N.F. and Price, D.H., "Control of formation of two distinct classes of RNA polymerase II elongation complexes," Mol Cell Biol 12:2078-2090 (1992).
Marshall, et al., "Drosophila RNA polymerase II elongation factor DmS-II has homology to mouse S-II and sequence similarity to yeast PPR2," Nucleic Acids Res 18:6293-6298 (1990).
Mitani, et al., "Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation," Blood 85:2017-2024 (1995).
Mitchell, P.J. and Tijan, R., Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins, Science 245:371-378 (1989).
Nakanishi, et al., "Structure-function relationship of yeast S-II terms of stimulation of RNA polymerase II, arrest relief, and suppression of 6-azauracil sensitivity," J Biol Chem 270:8991-8995 (1995).
Price, et al., "Dynamic interaction between a Drosophila transcription factor and RNA polymerase II," Mol Cell Biol 9:1465-1475 (1989).
Reines, D., "Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II," J Biol Chem 267:3795-3800 (1992).
Shilatifard, et al., An RNA polymerase II elongation factor encoded by the human ELL gene, Science 271:1873-1876 (1996).
Tan, et al., "Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II," J Biol Chem 269:25684-25691 (1994).
Thirman, et al., "Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia," Proc Natl Acad Sci USA 91:12110-12114 (1994).
Walker, et al., "Distantly related sequences in the .alpha.-and .beta.-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold," EMBO J 1:945-951 (1982).
Whaley, et al., "Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic Hippel-Lindau aberrations in sporadic renal cell carcinoma," Am J Hum Genet 55:1092-1102 (1994).
Yankulov, et al., "Transcriptional elongation by RNA polymerase II is stimulated by transactivators," Cell 77:749-759 (1994).
Conaway Joan W.
Conaway Ronald C.
Ketter James
Oklahoma Medical Research Foundation
Sandals William
LandOfFree
Elongin A and C functional domains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Elongin A and C functional domains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elongin A and C functional domains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1487562